The DTP Vaccine Lots: Thousands of Children Injured by Highly Toxic Formulas Containing Cholera Antigens

The DTP Vaccine Lots: Thousands of Children Injured by Highly Toxic Formulas Containing Cholera Antigens

A recent investigation into vaccine manufacturing processes has revealed that not all vaccine lots are created equal.

The use of a higher volume of adjuvant, which is used to enhance the immune response, can result in more numerous and severe side effects. Additionally, vaccine manufacturers may mistakenly mix up or mislabel the antigens used in a vaccine lot, leading to potentially harmful consequences.

This issue was particularly prevalent in the 1960s and 70s when the DTP vaccine, designed to prevent diphtheria, tetanus, and pertussis, caused clusters of brain* damage and even death in infants. It was discovered that some vaccine lots were up to 14 times stronger and more toxic than what had been tested for safety and effectiveness. These lots contained cholera antigens and high-dose adjuvants that were not appropriate for the infants’ body weight and blood volume.

The UK Department of Health commissioned an analysis of the suspect DTP vaccine batches after doctors reported an increase in brain*-damaged infants. It was found that two batches contained cholera antigens and were significantly more potent than the standard dose established by the government. Another 14 batches were never subjected to necessary toxicity tests, resulting in thousands of babies being exposed to potentially harmful vaccines.

One of the victims of these poorly manufactured vaccines was Kenneth Best. After fighting for over two decades, his family was granted 2.75 million pounds in compensation for his brain* injury caused by the DTP vaccine. Kenneth experienced severe developmental issues, including nonverbal communication, self-harming behavior, and mental and emotional underdevelopment. His symptoms align with a severe autism diagnosis, which has become increasingly prevalent over the years.

The Irish Supreme Court also awarded compensation to Kenneth, accusing Glaxo Wellcome, the vaccine manufacturer, of negligence and poor quality control. Further investigation revealed that Glaxo had used an even more toxic version of the DTP vaccine on hundreds, if not thousands, of babies.

While Glaxo paid compensation for Kenneth’s injury, the company did not admit fault and maintains that their vaccines are safe and crucial for disease prevention. However, more and more families are coming forward with accounts of vaccine injuries in their children, suggesting a link between vaccines and chronic diseases, neurodevelopment disorders, and autism.

Read more…